Results 81 to 90 of about 1,048,370 (263)

Cis-hetero-misogyny online

open access: yes, 2019
This article identifies five genres of anti-queer hate speech found in The Australian’s Facebook comments sections, exposing and analyzing the ways in which such comments are used to derogate cisgender and (often) heterosexual women.
Louise Richardson-Self (14747941)
core  

Cis-Isomers of Photosensitive Cationic Azobenzene Surfactants in DNA Solutions at Different NaCl Concentrations: Experiment and Modeling

open access: yes, 2021
The DNA interaction with cis-isomers of photosensitive azobenzene-containing surfactants was studied by both experimental methods and computer simulation.
Svetlana Santer (1559020)   +13 more
core   +1 more source

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

open access: yesMolecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla   +9 more
wiley   +1 more source

Data_Sheet_1_Palladium and Platinum 2,4-cis-amino Azetidine and Related Complexes.PDF

open access: yes, 2018
Seven N,N'-palladium(II) chloride complexes, one N,N'-palladium(II) acetate complex of 2,4-cis-azetidines where prepared and analyzed by single crystal XRD.
Andrew G. Leach (1720261)   +4 more
core   +1 more source

Recurrent Modification of a Conserved Cis-Regulatory Element Underlies Fruit Fly Pigmentation Diversity [PDF]

open access: yes, 2013
The development of morphological traits occurs through the collective action of networks of genes connected at the level of gene expression. As any node in a network may be a target of evolutionary change, the recurrent targeting of the same node would ...
Salomone, Joseph R.   +28 more
core   +2 more sources

Differential expression of cancer‐related genes supports prediction of poor response to first‐line treatments in T‐ALL pediatric patients with high minimal residual disease

open access: yesMolecular Oncology, EarlyView.
In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera   +11 more
wiley   +1 more source

cis-eQTL (FDR < 0.05) counts across MESA populations.

open access: yes, 2018
cis-eQTL (FDR < 0.05) counts across MESA populations.
Angela Andaleon (5620598)   +9 more
core   +1 more source

Targeting of protein ERGIC-53 to the ER/ERGIC/cis-Golgi recycling pathway [PDF]

open access: yes, 1995
ERGIC-53 is a lectin-type membrane protein that continuously recycles between the ER, ER-Golgi intermediate compartment (ERGIC) and the cis-Golgi. To identify the targeting signals that mediate this recycling, N-glycosylated and myc-tagged variants of ...
R Schindler   +5 more
core   +1 more source

Cis-eQTLs in the HDAC9-associated CAD risk locus in STARNET.

open access: yes, 2022
This analysis was performed using STARNET datasets, in all 9 STARNET tissues/cells (SF, VF, AOR, LIV, SKLM, BLOOD, MAM, MP, FC). eQTLs are shown for FDR P ≤ 0.05.
Daniella Kadian-Dodov (3280761)   +18 more
core   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy